UBS Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.42M | Buy |
|
|||||
|
2025
Q2 | $1.16M | Sell |
|
|||||
|
2025
Q1 | $3.74M | Sell |
|
|||||
|
2024
Q4 | $12.7M | Sell |
|
|||||
|
2024
Q3 | $22.5M | Buy |
|
|||||
|
2024
Q2 | $8.61M | Buy |
|
|||||
|
2024
Q1 | $6.62M | Buy |
|
|||||
|
2023
Q4 | $1.65M | Buy |
|
|||||
|
2023
Q3 | $485K | Buy |
|
|||||
|
2023
Q2 | $254K | Buy |
|
|||||
|
2023
Q1 | $16.7K | Sell |
|
|||||
|
2022
Q4 | $111K | Buy |
|
|||||
|
2022
Q3 | $13K | Buy |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $98K | Buy |
|
|||||
|
2021
Q4 | $5K | Buy |
|
|||||
|
2021
Q3 | $0 | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $51K | Sell |
|
|||||
|
2020
Q4 | $209K | Buy |
|